Nexbook stands as an effective pharmaceutical solution, tackling gastric acid-related issues with a specialized formula. At the core of its efficacy lies the active ingredient, bis(5-methoxy-2sulfinyl]-1H-benzimidazole-1-yl) magnesium trihydrate. This compound capitalizes on the unique properties of esomeprazole, the S-isomer of omeprazole, known for its targeted approach to reducing gastric acid secretion.
Mode Of Action:
Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell.
Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+K+-ATPase – the acid pump and inhibits both basal and stimulated acid secretion
Indications:
- Gastroesophageal Reflux (GERD)
- Erosive Esophagitis
- NSAID-associated gastropathies
- H-Pylori eradication
- Symptomatic GERD (heartburn) in patients
Dosage:
As prescribed and directed by physician.
Instructions for usage:
- As directed by physician
STORAGE:
Store at a temperature below 30°C in dry place. Keep out of reach of children.
Contraindications:
Pregnancy & lactation.
Known hypersensitivity to esomeprazole, any ingredient in the formulation, or other substituted benzimidazoles
FAQ’s:
It’s crucial to inform your physician about all medications and supplements you are taking. They can provide guidance on potential interactions and ensure the safest and most effective use of Nexbook in your personalized treatment plan.
Nexbook is contraindicated during pregnancy and lactation. It’s important to consult a healthcare professional for suitable alternatives.
Absolutely! Nexbook, with its proven PPI combination, has stood the test of time in providing effective and enduring relief for gastric acid-related conditions.